Zobrazeno 1 - 10
of 563
pro vyhledávání: '"M, Zwaan"'
Autor:
Edoardo Pennesi, Erica Brivio, Anneke C. J. Ammerlaan, Yilin Jiang, Vincent H. J. van der Velden, H. Berna Beverloo, Barbara Sleight, Franco Locatelli, Benoit Brethon, Claudia Rossig, Gernot Engstler, Anna Nilsson, Benedicte Bruno, Arnaud Petit, Bella Bielorai, Carmelo Rizzari, Fanny Rialland, Alba Rubio-San-Simón, Francisco J. Bautista Sirvent, Cristina Diaz-de-Heredia, Susana Rives, Christian M. Zwaan
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Inotuzumab Ozogamicin (InO) is a CD22-directed antibody conjugated with calicheamicin. The Phase 1B of the ITCC-059 trial tested InO combined with chemotherapy in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Relapsed /refractory
Externí odkaz:
https://doaj.org/article/c0f7af8ee2a94f19b2f8e805c1f3d42c
Autor:
Eline A. M. Zijtregtop, Ilse Tromp, Rana Dandis, Christian M. Zwaan, King H. Lam, Friederike A. G. Meyer-Wentrup, Auke Beishuizen
Publikováno v:
Pathology and Oncology Research, Vol 28 (2022)
Immunohistochemical markers are associated with treatment outcome in adults with classical Hodgkin Lymphoma (cHL). Studies in children are scarce and inconsistent. We investigated in 67 children with cHL, whether the expression of CD15, CD30, PAX5, P
Externí odkaz:
https://doaj.org/article/ebdc61ab90cd4171baba6409c5905056
Autor:
Eline A. M. Zijtregtop, Friederike Meyer‐Wentrup, Wai‐Chu Wong, Raoull Hoogendijk, Marta Lopez‐Yurda, Christian M. Zwaan, Auke Beishuizen
Publikováno v:
eJHaem, Vol 1, Iss 1, Pp 152-160 (2020)
Abstract Pediatric classical Hodgkin's lymphoma (cHL) is characterized by Hodgkin Reed‐Sternberg cells located in an inflammatory microenvironment. Blood biomarkers result from active crosstalk between these cells. One promising biomarker in adult
Externí odkaz:
https://doaj.org/article/87c34c5b6f704ee3be92ca0a49c7e344
Autor:
Marjon H Cnossen, Frank W G Leebeek, Ron A A Mathôt, M Coppens, MJHA Kruip, S Polinder, K Fischer, R Liesner, K Fijnvandraat, Laura H Bukkems, PW Collins, P Chowdary, K Meijer, A Janssen, MH Cnossen, Jessica M Heijdra, Wala Al Arashi, Nico C B de Jager, Michael E Cloesmeijer, Christian M Zwaan, FWG Leebeek, RAA Mathôt, RYJ Tamminga, BAP Laros-van Gorkom, P Brons, SEM Schols, FJM van der Meer, HCJ Eikenboom, REG Schutgens, F Heubel-Moenen, L Nieuwenhuizen, P Ypma, MHE Driessens, CM Zwaan, I van Vliet, D Keeling, J Lock, HCAM Hazendonk, I van Moort, T Preijers, JM Heijdra, NCB de Jager, MCHJ Goedhart, LH Bukkems, W Al Arashi, ME Cloesmeijer
Publikováno v:
BMJ Open, Vol 12, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/1965d1889ddf4cbeb8a1d66664e6a252
Autor:
Eva M. Zwaan, Elena S. Cheung, Alexander J. J. IJsselmuiden, Carlo A. J. Holtzer, Ton A. R. Schreuders, Marcel J. M Kofflard, J. Henk Coert
Publikováno v:
Journal of Interventional Cardiology, Vol 2022 (2022)
Objectives. To determine the incidence of upper extremity dysfunction (UED), after a transradial percutaneous coronary intervention (TR-PCI). Background. Transradial approach (TRA) is the preferred approach for coronary interventions. However, upper
Externí odkaz:
https://doaj.org/article/4c999dc010534e4b988a24e01674ea45
Autor:
A. Vora, T. Bhatla, D. Teachey, F. Bautista, J. Moppett, P. Velasco Puyó, C. Micalizzi, C. Rossig, N. Shukla, G. Gilad, F. Locatelli, A. Baruchel, C. M. Zwaan, E. A. Raetz, N. Bandyopadhyay, L. Lopez Solano, R. M. Dennis, R. Carson, L. E. Hogan
Publikováno v:
HemaSphere, Vol 6, Pp 260-261 (2022)
Externí odkaz:
https://doaj.org/article/199bcd5e5a07454880929b653eac0420
Autor:
Edoardo Pennesi, Erica Brivio, Anneke C.J. Ammerlaan, Yilin Jiang, Vincent H.J. van der Velden, Berna Beverloo, Barbara Sleight, Susana Rives, Cristina Díaz de Heredia Rubio, Francisco J. Bautista Sirvent, Alba Rubio-San-Simón, Fanny Rialland, Carmelo Rizzari, Bella Bielorai, Arnaud Petit, Bénédicte Bruno, Ingrid Øra, Anna Nilsson, Gernot Engstler, Claudia Rossig, Benoit Brethon, Franco Locatelli, Christian M. Zwaan
Publikováno v:
Blood. 140:8976-8978
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2eb394cc2ac3bb18f6fea3a68d278e39
https://doi.org/10.1182/blood-2022-163056
https://doi.org/10.1182/blood-2022-163056
Autor:
Edoardo Pennesi, Erica Brivio, Kathleen B. Pelletier, Ying Chen, Alwin D.R. Huitema, Yilin Jiang, Anneke C.J. Ammerlaan, Barbara Sleight, Franco Locatelli, Inge M. Van Der Sluis, Claudia Rossig, Christiane Chen-Santel, Bella Bielorai, Arnaud Petit, Jan Stary, Lucie Sramkova, Cristina Díaz de Heredia Rubio, Susana Rives, Aengus O'Marcaigh, Carmelo Rizzari, Gernot Engstler, Karsten Nysom, Alba Rubio-San-Simón, Francisco J. Bautista Sirvent, Bénédicte Bruno, Yives Bertrand, Benoit Brethon, Fanny Rialland, Genevieve Plat, Uta Dirksen, May Garrett, Christian M. Zwaan
Publikováno v:
Blood. 140:8845-8847
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e04ea6a805e8608846bc6e5fae5e3feb
https://doi.org/10.1182/blood-2022-165954
https://doi.org/10.1182/blood-2022-165954
Autor:
Edoardo Pennesi, Naomi Michels, Erica Brivio, Vincent H. J. van der Velden, Yilin Jiang, Adriana Thano, Anneke J. C. Ammerlaan, Judith M. Boer, H. Berna Beverloo, Barbara Sleight, Ying Chen, Britta Vormoor-Bürger, Susana Rives, Bella Bielorai, Claudia Rössig, Arnaud Petit, Carmelo Rizzari, Gernot Engstler, Jan Starý, Francisco J. Bautista Sirvent, Christiane Chen-Santel, Benedicte Bruno, Yves Bertrand, Fanny Rialland, Geneviève Plat, Dirk Reinhardt, Luciana Vinti, Arend Von Stackelberg, Franco Locatelli, Christian M. Zwaan
Publikováno v:
Leukemia
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Leukemia, 36(6), 1516-1524. Nature Publishing Group
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Leukemia, 36(6), 1516-1524. Nature Publishing Group
Inotuzumab Ozogamicin is a CD22-directed antibody conjugated to calicheamicin, approved in adults with relapsed or refractory (R/R) B cell acute lymphoblastic leukemia (BCP-ALL). Patients aged 1–18 years, with R/R CD22 + BCP-ALL were treated at the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33daf3144da595f4e65dbc30299e722a
https://doi.org/10.1038/s41375-022-01576-3
https://doi.org/10.1038/s41375-022-01576-3
Autor:
Elizabeth Fox, Michael Berntgen, Alfonso Quintás-Cardama, Veronique Minard-Colin, Susan L. Weiner, André Baruchel, Laura Pearce, Karsten Nysom, Andrew D.J. Pearson, Danielle H. Taylor, Christian M. Zwaan, Nirali N. Shah, Yousif Matloub, Ivan D. Horak, Gregory H. Reaman, Gilles Vassal, Koen Norga, Claudia Rossig, Dominik Karres, Lori A. Ehrlich, Martina Schüßler-Lenz, Alberto S. Pappo, Joe McDonough, Martina A. Sersch, Nick Richardson, Donna Ludwinski, Abraham Bassan, Eric Bleickardt, Nicole Scobie, Stephen Gottschalk, Rob Pieters, Sarah K. Tasian, Courtney Johnson, Teresa de Rojas, Malcolm A. Smith, Franca Ligas, Lynley V. Marshall, Shannon L. Maude, Brenda J. Weigel, Nick Bird, Najat Bouchkouj, Behzad K. Masouleh, Sarah Beaussant Cohen, Delphine Heenen, Rosanna Ricafort, G. Lesa, Linda Hanssens, Peter F. Bross, Carrie Brownstein, Crystal L. Mackall, Martin Pule, Douglas S. Hawkins, Jaroslav Sterba, Maksim Mamonkin
Publikováno v:
European Journal of Cancer. 160:112-133
The seventh multi-stakeholder Paediatric Strategy Forum focused on chimeric antigen receptor (CAR) T-cells for children and adolescents with cancer. The development of CAR T-cells for patients with haematological malignancies, especially B-cell precu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::109dc83dd17c2fd2077a3e812e4df67f
https://doi.org/10.1016/j.ejca.2021.10.016
https://doi.org/10.1016/j.ejca.2021.10.016